Resveratrol slows the tumourigenesis of pancreatic cancer by inhibiting NFκB activation

Resveratrol slows the tumourigenesis of pancreatic cancer by inhibiting NFκB activation

Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumour with an extremely poor prognosis due to its insidious initiation and a lack of therapeutic strategies. Resveratrol suppresses pancreatic cancer progression and attenuates pancreatitis by modulating multiple targets, including nucle...

Full description

Bibliographic Details
Main Authors: Weikun Qian, Qigui Xiao, Lin Wang, Tao Qin, Ying Xiao, Jie Li, Yangyang Yue, Cancan Zhou, Wanxing Duan, Qingyong Ma, Jiguang Ma
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:Biomedicine & Pharmacotherapy
Subjects:
pancreatic ductal adenocarcinoma
resveratrol
nuclear factor kappa B
tumourigenesis
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332220303085

Internet

http://www.sciencedirect.com/science/article/pii/S0753332220303085

Similar Items